V. Vargemezis

发表

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple‐dose, phase II study

F. C. Dougherty, S. Niemczyk, W. Sułowicz, 2006, International journal of clinical practice.

Corticosteroids and Ciclosporin A in Idiopathic Membranous Nephropathy: Higher Remission Rates of Nephrotic Syndrome and Less Adverse Reactions than after Traditional Treatment with Cytotoxic Drugs

E. Vardaki, K. Siamopoulos, P. Passadakis, 2007, American Journal of Nephrology.

Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis

J. Lambris, P. Passadakis, Hongchang Qu, 2010 .

D-dimer, factor VIII and von Willebrand factor predict a non-dipping pattern of blood pressure in hypertensive patients

P. Passadakis, Vasilios Papadopoulos, K. Tsatalas, 2013, International Urology and Nephrology.

Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in idiopathic membranous nephropathy.

A. Giatromanolaki, E. Sivridis, S. Touloupidis, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of Iron Loading on Peripheral Blood Lymphocyte Subsets and on Circulating Cytokine Levels in Iron-Depleted Hemodialysis Patients Receiving Erythropoietin

I. Tsouchnikas, D. Tsakiris, P. Pasadakis, 2007, Nephron Clinical Practice.

Effect of 1-Year Oral α-Tocopherol Administration on Anticardiolipin Antibodies in Hemodialysis Patients

T. Eleftheriadis, G. Antoniadi, V. Liakopoulos, 2005, Renal failure.

Impaired T Cell Proliferation and Zeta Chain Phosphorylation after Stimulation with Staphylococcal Enterotoxin-B in Hemodialysis Patients

T. Eleftheriadis, K. Papazisis, A. Kortsaris, 2004, Nephron Clinical Practice.

Low T3 syndrome and long-term mortality in chronic hemodialysis patients.

A. Papagianni, E. Thodis, S. Panagoutsos, 2015, World journal of nephrology.

of Nephrology Low T3 syndrome and long-term mortality in chronic hemodialysis patients Prospective Study

A. Papagianni, E. Thodis, S. Panagoutsos, 2015 .

Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.

K. Kyriacou, K. Voskarides, A. Pierides, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.

J. Lambris, P. Passadakis, Hongchang Qu, 2010, Blood.

thrombosis Complement anaphylatoxin C5a contributes to hemodialysis-associated

J. Lambris, P. Passadakis, Hongchang Qu, 2011 .

Acute Exercise May Exacerbate Oxidative Stress Response in Hemodialysis Patients

I. Fatouros, I. Michailidis, I. Douroudos, 2008, Nephron Clinical Practice.

Biocompatibility Study Based on Differential Sequestration Kinetics of CD14+CD16+ Blood Monocyte Subsets with Different Dialyzers

I. Griveas, P. Passadakis, G. Sakellariou, 2006, Renal failure.

Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.

John D Lambris, P. Passadakis, Hongchang Qu, 2010, Blood.